null

Tisotumab Biosimilar (Anti-F3) Antibody (HDBS0105)

SKU:
HDBS0105
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CD142
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
$479
Frequently bought together:

Description

system_update_altDatasheet

Tisotumab (Anti-F3) Biosimilar Antibody (HDBS0105)

The Tisotumab Biosimilar Anti-F3 Antibody is a cutting-edge research tool for scientists investigating F3, a cell surface protein known for its role in tumor growth and metastasis. This monoclonal antibody, produced using the latest biotechnology techniques, has been rigorously tested for its specificity and sensitivity in various assays, including immunohistochemistry and flow cytometry.F3, also known as tissue factor pathway inhibitor 2 (TFPI-2), is a critical player in the regulation of blood coagulation and angiogenesis, making it a promising target for cancer therapy research.

By specifically binding to F3, this antibody allows researchers to accurately detect and study the protein's expression in different cancer cell lines and tissue samples.The Tisotumab Biosimilar Anti-F3 Antibody holds great potential for advancing our understanding of cancer biology and developing novel therapeutic strategies targeting F3. Its high affinity and specificity make it an invaluable tool in the fight against cancer, offering new insights into the mechanisms driving tumor progression and metastasis.